American College of Medical Toxicology (ACMT) Cautions Against Off-Label Prescribing of Ivermectin for the Prevention or Treatment of COVID-19.
作者信息
Calello Diane P, Kazzi Ziad, Stolbach Andrew
机构信息
Rutgers New Jersey Medical School, Newark, USA.
Emory University, Atlanta, GA, Georgia.
出版信息
J Med Toxicol. 2022 Jan;18(1):69-70. doi: 10.1007/s13181-021-00866-z. Epub 2022 Jan 10.
Abstract
摘要
相似文献
1
American College of Medical Toxicology (ACMT) Cautions Against Off-Label Prescribing of Ivermectin for the Prevention or Treatment of COVID-19.美国医学毒理学学会（ACMT）对伊维菌素用于预防或治疗COVID-19的非标签处方发出警告。
J Med Toxicol. 2022 Jan;18(1):69-70. doi: 10.1007/s13181-021-00866-z. Epub 2022 Jan 10.
2
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic.美国毒理学会立场声明：COVID-19大流行期间的超说明书用药
J Med Toxicol. 2020 Jul;16(3):342-345. doi: 10.1007/s13181-020-00784-6. Epub 2020 Jun 4.
3
Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model.伊维菌素在叙利亚仓鼠模型中不能预防SARS-CoV-2感染。
Microorganisms. 2022 Mar 16;10(3):633. doi: 10.3390/microorganisms10030633.
4
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. American Journal of Therapeutics, 28, e434-e460, July 2021.伊维菌素用于预防和治疗新冠病毒感染：一项为临床指南提供信息的系统评价、荟萃分析和试验序贯分析。《美国治疗学杂志》，第28卷，e434 - e460，2021年7月。
Am J Ther. 2021 Aug 27;28(5):e573-e576. doi: 10.1097/MJT.0000000000001442.
5
Self-prescribed Ivermectin use is associated with a lower rate of seroconversion in health care workers diagnosed with COVID, in a dose-dependent response.自我处方伊维菌素的使用与 COVID 确诊医护人员的血清转化率降低有关，且呈剂量依赖性反应。
Braz J Infect Dis. 2021 Jul-Aug;25(4):101603. doi: 10.1016/j.bjid.2021.101603. Epub 2021 Aug 12.
6
Impact of misinformation on ivermectin internet searches and prescribing trends during COVID-19.新冠疫情期间错误信息对伊维菌素网络搜索和处方趋势的影响。
J Public Health (Oxf). 2023 Aug 28;45(3):631-635. doi: 10.1093/pubmed/fdac152.
7
A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin.一种 COVID-19 预防药物？伊维菌素预防性给药与较低的发病率相关。
Int J Antimicrob Agents. 2021 Jan;57(1):106248. doi: 10.1016/j.ijantimicag.2020.106248. Epub 2020 Nov 28.
8
A five-day course of ivermectin may reduce the duration of COVID-19 illness.为期五天的伊维菌素疗程可能会缩短新冠病毒疾病的病程。
Int J Infect Dis. 2021 Sep;110:93-94. doi: 10.1016/j.ijid.2021.07.050. Epub 2021 Jul 26.
9
Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project.依维莫司相关不良反应在 COVID-19 的治疗和预防中向 FACT 药物警戒项目报告。
Clin Toxicol (Phila). 2022 Aug;60(8):942-946. doi: 10.1080/15563650.2022.2070187. Epub 2022 May 10.
10
Standard Dose Ivermectin for COVID-19.用于治疗新冠肺炎的标准剂量伊维菌素
Chest. 2021 May;159(5):2111-2112. doi: 10.1016/j.chest.2021.03.003.
引用本文的文献
1
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review.药物重新利用和天然产物对抗新型冠状病毒的有效性：一项综合综述。
Clin Pharmacol. 2024 Jan 4;16:1-25. doi: 10.2147/CPAA.S429064. eCollection 2024.
本文引用的文献
1
Serious Ivermectin Toxicity and Human Nonsense Mutations.严重的伊维菌素毒性与人类无义突变
N Engl J Med. 2020 Aug 20;383(8):787-789. doi: 10.1056/NEJMc1917344.
2
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic.美国毒理学会立场声明：COVID-19大流行期间的超说明书用药
J Med Toxicol. 2020 Jul;16(3):342-345. doi: 10.1007/s13181-020-00784-6. Epub 2020 Jun 4.
Zotero 插件